EECP and its APPLICATION

1.    Sequential External Counterpulsation (SECP) in China.
Zheng ZS, Li TM, Kambic H, Chen GH, Yu LG, Cai SR, Zhan CY, Chen YC, Wo SX, Chen GW, Ma H, Chen PJ.
Transactions of the American Society of Artificial Internal Organs. 1983 29:599

2.     New Sequential External Counterpulsation for the Treatment of Acute Myocardial Infarction.
Zheng ZS, Yu LQ, Cai SR, Kambic H, Li TM, Ma H, Chen PZ, Huang BJ, Nose Y.
Transactions of the American Society of Artificial Internal Organs. 1984 Nov;8(4):470‑477.

3.     Current status of External Counterpulsation.
Soroff HS, Hui J, Giron F.
Critical Care Clinics 1986 Ap 2 (2):277-295

4.     Prior Revascularization Increases the Effectiveness of Enhanced External Counterpulsation
Lawson WE, Hui JCK, Guo T, Burger L, Cohn PF.
Clinical Cardiology 1998 Nov;21(11):841-844.

5.     Maximizing the Hemodynamic Benefit of Enhanced External Counterpulsation.
Suresh K, Simandl S, Lawson WE, Hui JCK, Lillis O, Burger L, Guo T, Cohn PF.
Clinical Cardiology. 1998 Sep;21(9):649-653.

6.     (A Comparative Study of Finger Plestismography and Aortic Pressure for Monitoring The Effect of External Counterpulsation).
Wu G, Zheng SZ, Du Z, Zhang M, Hu C, Liao Y, Zhao S, Yang S, Wu F.
Journal of Biomedical Engineering.1999 Dec; 16(4):493-6.

7.    (The Study of the Control System of New Generation EECP)
Li H, Zheng Z.
Zhongguo Yi Liao Qi Xie Za Zhi 1999 Jul; 23(4):187-9.

8.    Pneumatic External Counterpulsation: A New Noninvasive Method to Improve Organ Perfusion.
Werner D, Schneider M, Weise M, Nonnast-Daniel B, Daniel WG.
American Journal of Cardiology. 1999 Oct 15;84(8):950-952

9.    Does Higher Diastolic Augmentation Predict Clinical Benefit from Enhanced External Counterpulsation?: Data from the International EECP Patient Registry (IEPR).
Michaels AD, Kennard ED, Kelsey SE, Holubkov R, Soran O, Spence S, Chou TM.
Clinical Cardiology. 2001 Jun;24(6):453-458.

10.   Numerical Simulation of Enhanced External Counterpulsation.
Ozawa ET, Bottom KE, Xiao X, Kamm RD.
Annals of Biomedical Engineering. 2001 Apr;29(4):284-297.

11.   Predictors of Adverse Outcomes in Treating Angina Patients with Enhanced External Counterpulsation.
Lawson WE, Fleishman B, Manzo K, Kennard ED, Holubkov R, Kelsey SF.
Proceedings of the 2nd International Congress on Heart Disease - New Trends in Research, Diagnosis and Treatment (International Academy of Cardiology). 2001 Jul 21-24;(Washington DC, USA):231-234.
Journal of Heart Disease 2001, 2(1); (abst 366).

12.   Relation of the Pattern of Diastolic Augmentation During a Course of Enhanced External Counterpulsation (EECP) to Clinical Benefit [from the International EECP Patient Registry (IEPR)].
Lakshmi MV, Kennard ED, Kelsey SF, Holubkov R, Michaels AD.
American Journal of Cardiology. 2002 Jun 1;89(11):1303-1305.

13.   Enhanced External Counterpulsation. Bringing the concept of Intraaortic Balloon Pump to the Outpatient Setting.
Lonergan-Thomas H, Brennan S, Cianci P, Silver A.
Dimensions of Critical Care Nursing 2004, May/jun,23(3):119-121.

14.   Improvement of Oxygen Metabolism in Ischemic Myocardium as a Result of Enhanced External Counterpulsation with Heparin Pretreatment for Patients with Stable angina.
Masuda D, Fujita M, Nohara R, Matsumori A, Sasayama S.
Heart Vessels. 2004 Mar;19(2):59-62.

15.   Predictors of Benefit in Angina Patients One Year After Completing Enhanced External Counterpulsation: Initial Responders to Treatment Versus Nonresponders.
Lawson WE, Hui JCK, Kennard ED, Barsness G, Kelsey SF.
Cardiology. 2005 Apr 13;103(4):201-206

16.   Frequency and Efficacy of Repeat Enhanced External Counterpulsation for Stable Angina Pectoris (from the International EECP Patient Registry)
Michaels AD, Barsness GW, Soran O, Kelsey SF, Kennard ED, Hui JCK, and Lawson WE for the International EECP Patient Registry Investigators.
American Journal of Cardiology. 2005 Feb;95(3):394-397.

17.   Impact of Body Mass Index on Outcomes of Enhanced External Counterpulsation Therapy.
McCullough PA, Silver MA, Kennard ED, Kelsey SF, Michaels AD; IEPR Investigators.
American Heart Journal. 2006 Jan;151(1):139 e9-e13.

18.   Portable Enhanced External Counterpulsation for Acute Coronary Syndrome and Cardiogenic Shock: A Pilot Study
Cohen J, Grossman W, Michaels AD.
Clinical Cardiology. 2007 May;30(5):223-228

19.  Interaction between Cardioverter Defibrillator and Enhanced External Counterpulsation Device
Celik O., Aydin A., Yılmazer M.S., Sarıgül N.U., Gurol T., Dağdeviren B.
PACE 2013; 36:1104–1106.

 

ABSTRACTS

20.   Duplexsonographic Findings During Pneumatic External Counterpulsation.
Schneider M, Werner D, Nonnast-Daniel B, Garlichs C, Schwarz T, Schellong S, Daniel WG.
Circulation. 
1996 Oct 15;94(8 Suppl 1):I-608(3564).

21.   Maximizing the Hemodynamic Benefits of Enhanced External Counterpulsation.
Suresh K, Simandl S, Lawson WE, Hui JCK, Lillis O, Burger L, Guo T, Cohn PF.
Journal of Investigative Medicine. 
1997;45(3):213A.

22.   Pneumatic External Counterpulsation: A New Treatment for Selected Patients with Symptomatic Coronary Artery Disease.
Werner D, Freidel C, Kropp J, Weise M, Waltenberger J, Kranz A, Daniel WG.
European Heart Journal. 
1998 Aug;19(Abstr Suppl)58(P509).

23.   Pneumatic External Counterpulsation: A New Treatment for Selected Patients with Symptomatic Coronary Artery Disease.
Werner D, Freidel C, Kropp J, Weise M, Waltenberger J, Kranz A, Daniel WG.
Circulation. 
1998 Nov;98(17 Suppl):I-350(1839).

24.   Does Optimal Diastolic Augmentation Predict Clinical Benefit from Enhanced External Counterpulsation (EECP)? Data from the International Enhanced External Counterpulsation Patient Registry.
Michaels AD, Kennard ED. Kelsey S, Holubkov R, Spence S, Chou TM.
European Heart Journal. 
2000;21:173(P1043).

25.   Enhanced External Counterpulsation with Heparin Pretreatment Improves Exercise Capacity of Anginal Patients.
Fujita M, Masuda D, Nohara R, Sasayama S.
3rd International Congress on Coronary Artery Disease - Prevention to Intervention. 
2000 Oct 2-5; (Lyon, France):469.

26.   Predictors of Successful Response to Enhanced External Counterpulsation as Treatment of Angina Pectoris.
Lawson WE, Kennard ED, Hui JCK, Holubkov R, Kelsey S.
Circulation. 2000 Oct;102(18 Suppl 2):II-689(3332).

27.   Predictors of Adverse Outcomes in Treating Angina Patients with Enhanced External Counterpulsation.
Lawson WE, Fleishman B, Manzo K, Kennard ED, Holubkov R, Kelsey S.
The Journal of Heart Disease. 2001 Jul;2(1):92(366).

28.   What Factors Predict Congestive Heart Failure During Treatment of Angina Patients with Enhanced External Counterpulsation.
Lawson WE, Kennard ED, Holubkov R, Roberts JC, Feldman AM, Strobeck J.
Journal of Cardiac Failure. 
2001;7(3 Suppl 2):48(174).

29.   Is Diastolic Augmentation an Important Predictor of Treatment Completion for Patients with Left Ventricular Dysfunction Undergoing Enhanced External Counterpulsation for Angina?
Soran O, Michaels AD, Kennard ED, Kelsey SF, Holubkov R, Feldman AM.
Journal of Cardiac Failure. 2001:7(3 Suppl 2):99(371).

30.   The Improvements in Exercise Tolerance Post Enhanced External Counterpulsation in Patients with Chronic Refractory Angina are Related to Diastolic Augmentation.
Brown AS, Ho E, Heavey D, Dodd D, Horgan JHH.
Heart . 2001;85(Suppl I):P41(125).

31.   Improvement in Exercise Tolerance Post Enhanced External Counterpulsation is Related to the Peak Diastolic Augmentation Obtained.
Brown AS, Ho, E, Heavey D, Dodd D, Horgan JH.
European Heart Journal. 
2001 Sep;22:173(P1034).

32.   Diastolic Augmentation is an Independent Predictor of Improved Outcome in 3536 Patients Following Enhanced External Counterpulsation (EECP).
Brown A, Dodd D, Bagger P, Louis AA, Kennard ED, Kelsey SF, Horgan JH.
European Heart Journal. 2002 Aug;4(Abstr Suppl)567(2932).

33.   The Incidence of Repeat Enhanced External Counterpulsation (EECP) in Patients with Refractory Angina Who Are Not Candidates for Invasive Revascularization: Results from the International EECP Patient Registry.
Soran O.
Presented at the Society for Cardiac Angiography and Interventions 25th Annual Scientific Sessions, Seattle, WA USA, May 15-18, 2002.

34.   Predictors of Failure to Achieve Angina Reduction in Patients Who Are Not Candidates for Invasive Revascularization Treated with Enhanced External Counterpulsation.
Soran O, Kennard ED, Kelsey SF.
Catheterization and Cardiovascular Interventions. 2003 May;59(1):141-142 (D-24).

35.   Predictors of Failure to Achieve Angina Reduction in Patients Who Are Not Candidates for Invasive Revascularization Treated with Enhanced External Counterpulsation.
Soran O, Kennard ED, Kelsey SF.
Presented at the European Society of Cardiology Congress, Vienna, Austria, Aug 30-Sep 3, 2003.

36.   The Incidence and Independent Predictors of Repeat Enhanced External Counterpulsation in Patients with Left Ventricular Dysfunction.
Soran O, Kennard ED, Kelsey S.
Circulation. 2003 May 20;107(19):57(P61).

37.   Factors Predicting One Year Outcomes in Patients Treated with Enhanced External Counterpulsation.
Holubkov R, Kelsey SF.
Journal of Investigative Medicine. 2003 Mar;51(Suppl 2):S360 (26).

38.   Atrial Fibrillation Does Not Degrade the Clinical Benefits From Enhanced External Counterpulsation Therapy in Patients With Chronic Angina: Results From the International EECP Patient Registry.
Ochoa AB, O’Neill WW, Almany S.
Journal of the American College of Cardiology. 2003 Mar 19;41(6 Suppl A):(1148-114).

39.  Treatment Hours and Angina Improvement with Enhanced External Counterpulsation.
Lawson WE, Hui JC, Kennard ED.
Journal of the American College of Cardiology. 2004 Mar 3;43(5 suppl A):11A(1059-4).

40.   Comparison of Abbreviated Versus Full Course of Enhanced External Counterpulsation in Heart Failure Patients with One-year Follow-up.
Lawson WE.
Journal of Cardiac Failure. 2004 Aug;10(4 Suppl):pS84(245).

41.   Frequency and Results of Repeat Enhanced External Counterpulsation for Refractory Angina.
Lawson WE, Barsness G, Soran O, Kennard ED, Hui JC.
Journal of the American College of Cardiology. 2004 Mar 3;43(5 suppl A):308A(891-5).

42.   Diabetic Patients Have a Good Response to Enhanced External Counterpulsation Despite Lower Diastolic Augmentation Than Non-Diabetics.
Brown AS, Kennard ED, Linnemeier G, Soran O, Kelsey SF.
Presented at the European Society of Cardiology Congress. Aug 28-Sep 1, 2004:(Poster 2998).

43.   Acute Left Ventricular Filling Effects of Enhanced External Counterpulsation.
Illiou MC, Balice M, Megnien JL, Chironi G, Simon A, Sellier P, Levenson J.
Presented at the French Society of Cardiology, Paris, France, January 21-24, 2004.

44.   The Impact of Diastolic Augmentation Ratio on Treatment Outcomes After Enhanced External Counterpulsation Therapy for Angina Management.
Soran O, Kennard ED, Kelsey SF.
Catheterization and Cardiovascular Interventions. 2005 May;65(1):132(C-26).

45.   The Impact of Diastolic Augmentation Ratio on Treatment Outcomes in Patients with Left Ventricular Dysfunction Treated with Enhanced External Counterpulsation for Angina Management.
Soran O. Kennard ED, Kelsey SF.
Journal of Cardiac Failure. 2004 Aug;10(4 Suppl):pS67(181).

46.   Chronic Effects of Enhanced External Counterpulsation (EECP) Therapy on Ambulatory Activities Using a Digital Sleep Counter.
Van Eik L, deJong A, Franklin B, Grayson D.
Presented at the 20th Annual American Association of Cardiovascular and
Pulmonary Rehabilitation (AACVPR) Meeting
, Milwaukee, WI, USA, October 20-23, 2005.

47.   Can Smoking Improve the Benefits of Enhanced External Counterpulsation by Stimulating Angiogenesis in Areas of Ischemia?
Tartaglia J, Stenerson J, Kennard E.
Journal of Investigative Medicine. 2005 Mar;53(2):S401(86).

48.   Safety and Efficacy of Enhanced External Counterpulsation in Patients with Permanent Pacemakers in the Treatment of Chronic Heart Angina.
Braverman D, Tartaglia J, Stenerson J, Ramasamy S, Hui J.
Presented at the American Federation for Medical Research, Washington, DC, USA, April 29-30, 2005.

49.   Safety and Efficacy of Enhanced External Counterpulsation in Patients with Permanent Pacemakers in the Treatment of Chronic Heart Angina.
Tartaglia J, Stenerson Jr. J, Ramasamy S, Braverman D, Hui J.
Journal of Investigative Medicine. 2005 Mar;53(2):S402(87).

50.   Enhanced External Counterpulsation Improves Angina Status Independent of Candidacy for Invasive Revascularization.
Lawson WE, Barsness GW, Kennard ED, Hui JCK, Kelsey SF.
Journal of Investigative Medicine. 2005 Mar;53(2):S402(93).

51.   An Extended Course of Enhanced External Counterpulsation Provides Incremental Benefit in Patients with Persistent Angina.
Barsness GW, Kennard ED, Lawson WE.
Presented at the 2006 International External Counterpulsation Symposium, Guangzhou, China, May 5, 2006.

52.   Enhanced External Counterpulsation.
Omar SH.
Presented at Cardioalex 2006, Alexandria, Egypt, June 28-30, 2006.
Perfusion Augmentation Using Noninvasive Mechanical Counterpulsation (PUMP) Trial: Phase IIa Normal Controls
Wojner-Alexandrov AW, Ribo M, Sugg RM, Garami Z, Jesurum JT, Alexandrov AV.
Presented at the International Stroke Conference, Kissimmee, Florida, February 16-18, 2006.


eecpturkey.com © 2015